Anatomical patterns of patent foramen ovale (PFO): Do they matter for percutaneous closure?

Minerva Cardioangiologica

Volumn 57, Issue 3, 2009, Pages 275-284

  Presbitero, P ^a   Lanzone, A M ^b   Albiero, R ^b   Lisignoli, V ^a   Zavalloni Parenti, D ^a   Gasparini, G L ^a   Lodigiani, C ^a   Barbaro, C ^a   Fappani, A ^b   Barberis, G ^c   Rossi, M L ^a   Pagnotta, P ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b San Rocco di Franciacorta Private Clinic   (Italy)

^c Clinica Cellini   (Italy)

Author keywords

Echocardiography, transesophageal; Foramen ovale, patent, surgery; Ischemic attack, transient

Indexed keywords

ADULT; AGED; ANATOMY; ARTICLE; DEEP SEDATION; DEVICE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART ANEURYSM; HEART PALPITATION; HEART RIGHT ATRIUM; HEART RIGHT LEFT SHUNT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATENT FORAMEN OVALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RECURRENT DISEASE; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; VALSALVA MANEUVER;

ADULT; AGED; BALLOON OCCLUSION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FOLLOW-UP STUDIES; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; ITALY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 69549109741     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746
2. Khairy P, O' Donnel CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli. A sistematic review. Ann Intern Med 2003;139:753-760
3. Schräder R. Indication and techniques of transcatheter closure of patent foramen ovale. J Interv Cardiol 2003;16:543-551
4. Barratt DM, Harch PG, Van Meter K. Decompression illness in divers: a review of the literature. Neurologist 2002;8:186-202.
5. Schwerzmann M, Seiler C, Lipp E, Guzman R, Lövblad KO, Kraus M et al. Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Ann Intern Med 2001;134:21-24
6. Guérin P, Lambert V, Godart F, Legendre A, Petit J, Bourlon F et al. Transcatheter closure of patent foramen ovale in patients with platypnea-orthodeoxia: results of multicentric French registry. Cardiovasc Intervent Radiol 2005;28:164-168
7. Delgado G, Inglessis I, Martin-Herrero F et al. Management of platypnea-orthodeoxia syndrome by transcatheter closure of atrial communication: hemodynamic characteristics, clinical and echocardiographic outcome. J Invasive Cardiol 2004;16:578-582
8. Rao PS, Palacios IF, Bach RG, Bitar SR, Sideris EB. Platypnea- orthodeoxia: management by transcatheter buttoned device implantation. Catheter Cardiovasc Interv 2001;54:77-82.
9. Post MC, Luermans JGLM, Plokker HWM, Budts W. Patent foramen ovale and migraine. Catheter Cardiovasc Interv 2007;69:9-14.
10. Tsimikas S. Transcatheter closure of patent foramen ovale for migraine prophylaxis: hope or hype? J Am Coll Cardiol 2005;45:496-498
11. Reisman M, Christofferson RD, Jesurum J, Olsen JV, Spencer MP, Krabill KA et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardio 2005;45:492-495
12. Dowson A, Wilmshurst P, Mullen M, Muir K, Nightingale S. A prospective, multicenter, randomized, double blind, placebo-controlled trial to evaluate the efficacy of patent foramen ovale closure with the STARFLEX septal repair implant to prevent refractory migraine headaches: The MIST trial. Circulation 2008;117:1397-1404.
13. Schwerzmann M, Windecker S, Wahl A, Mehta H, Nedeltchev K, Mattle H et al. Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart 2004;90:186-190
14. Braun MU, Fassbender D, Haass M, Schraeder R, Scholtz W, Strasser RH. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cradiol 2002;39:2019-2025
15. Schneider B, Hofmann T, Justen MH, Meinertz T. Chiari's network: normal anatomic variant or risk factor for arterial embolic events? J Am Coll Cardiol 1995;26:200-210.
16. Wahl A, Krumsdorf U, Meier B, Sievert H, Ostermayer S, Billinger K et al. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol 2005;45:377-380
17. Martín F, Sánchez P, Doherty E, Colon-Hernandez PJ, Delgado G, Inglessis I et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002;106:1121-1126
18. Alameddine F, Block PC. Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: acute results from the FORECAST registry. Catheter Cardiovasc Interv 2004;62:512-516
19. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44:750-758
20. Homma S, Di Tullio MR, Sacco RL, Sciacca RR, Smith C, Mohr JP. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997;28:2376-2381